Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cormedix Inc (CRMD)
Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
CorMedix: Q3 Earnings Snapshot

CorMedix: Q3 Earnings Snapshot

CRMD : 3.25 (-1.22%)
CorMedix (CRMD) Q2 2023 Earnings Call Transcript

CRMD earnings call for the period ending June 30, 2023.

CRMD : 3.25 (-1.22%)
CorMedix: Q2 Earnings Snapshot

CorMedix: Q2 Earnings Snapshot

CRMD : 3.25 (-1.22%)
Why Shares of CorMedix Are Slumping Thursday

The company announced a stock sale and the sale of prefunded warrants.

CRMD : 3.25 (-1.22%)
Stocks Climb Before the Open as Investors Await Key U.S. GDP Data, Nike Earnings on Tap

September S&P 500 futures (ESU23) are up +0.24%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.27% this morning after three major U.S. benchmark indices ended the regular session mixed as investors...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
CCL : 14.71 (-0.34%)
NCLH : 16.10 (-0.49%)
NFLX : 573.35 (-0.31%)
NVDA : 674.72 (-2.85%)
GIS : 65.61 (-0.26%)
NKE : 105.27 (+1.91%)
RNO.P.DX : 38.327 (+3.38%)
HMB.S.DX : 140.700 (-2.13%)
MU : 81.49 (+0.97%)
WFC : 52.66 (+1.72%)
3 Biotech Stocks Losing Market Value

There is a growing demand for healthcare solutions, and the biotech industry will likely benefit from it. However, not all biotech stocks are well-positioned to capitalize on the industry tailwinds. Therefore,...

BCYC : 23.20 (+2.25%)
CRMD : 3.25 (-1.22%)
XXII : 0.1567 (-0.19%)
CorMedix (CRMD) Q1 2023 Earnings Call Transcript

CRMD earnings call for the period ending March 31, 2023.

CRMD : 3.25 (-1.22%)
CorMedix: Q1 Earnings Snapshot

CorMedix: Q1 Earnings Snapshot

CRMD : 3.25 (-1.22%)
How Much Upside is Left in CorMedix (CRMD)? Wall Street Analysts Think 198.21%

The average of price targets set by Wall Street analysts indicates a potential upside of 198.2% in CorMedix (CRMD). While the effectiveness of this highly sought-after metric is questionable, the positive...

CRMD : 3.25 (-1.22%)
CorMedix: Q4 Earnings Snapshot

CorMedix: Q4 Earnings Snapshot

CRMD : 3.25 (-1.22%)

Barchart Exclusives

Trading Alert: February 22nd Iron Condor Screener Results
A short iron condor is an income strategy that aims to profit when a stock stays within a specified range over the course of the trade. The trade is composed of four options with the same expiration: Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar